Lexicon Pharmaceuticals Stock Market Value
| LXRX Stock | USD 0.80 0.02 2.44% |
| Symbol | Lexicon |
Lexicon Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceuticals. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (0.74) | Revenue Per Share 0.018 | Quarterly Revenue Growth 9.802 | Return On Assets (0.44) |
The market value of Lexicon Pharmaceuticals is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lexicon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexicon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lexicon Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lexicon Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lexicon Pharmaceuticals.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Lexicon Pharmaceuticals on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Lexicon Pharmaceuticals or generate 0.0% return on investment in Lexicon Pharmaceuticals over 30 days. Lexicon Pharmaceuticals is related to or competes with BioLineRx, Ardelyx, Seres Therapeutics, Immunitybio, X4 Pharmaceuticals, Elevation Oncology, and Mereo BioPharma. Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization... More
Lexicon Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lexicon Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lexicon Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 46.58 | |||
| Value At Risk | (7.55) | |||
| Potential Upside | 6.7 |
Lexicon Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexicon Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lexicon Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Lexicon Pharmaceuticals historical prices to predict the future Lexicon Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (1.97) | |||
| Treynor Ratio | (0.82) |
Lexicon Pharmaceuticals Backtested Returns
Lexicon Pharmaceuticals has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14% return per unit of risk over the last 3 months. Lexicon Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexicon Pharmaceuticals' Risk Adjusted Performance of (0.11), mean deviation of 3.69, and Standard Deviation of 6.12 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.15, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lexicon Pharmaceuticals will likely underperform. At this point, Lexicon Pharmaceuticals has a negative expected return of -0.87%. Please make sure to verify Lexicon Pharmaceuticals' accumulation distribution, as well as the relationship between the day median price and price action indicator , to decide if Lexicon Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
Lexicon Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Lexicon Pharmaceuticals time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lexicon Pharmaceuticals price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Lexicon Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lexicon Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Lexicon Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lexicon Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Lexicon Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Lexicon Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lexicon Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lexicon Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lexicon Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lexicon Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Lexicon Pharmaceuticals Lagged Returns
When evaluating Lexicon Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lexicon Pharmaceuticals stock have on its future price. Lexicon Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lexicon Pharmaceuticals autocorrelation shows the relationship between Lexicon Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Lexicon Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.